March 3, 2025

Ron Finklestien

Top Momentum Stocks to Consider for March 3rd

Stocks to Buy Now: Strong Momentum and Rankings for March 3rd

On March 3rd, investors can consider three stocks with a buy ranking and robust momentum characteristics:

Sterling Infrastructure, Inc. (STRL)

This e-infrastructure, transportation, and building solutions company holds a Zacks Rank #1. Over the past 60 days, the Zacks Consensus Estimate for its current year earnings has risen nearly 14%.

Performance Overview


Sterling Infrastructure, Inc. Price and Consensus

Sterling Infrastructure, Inc. price-consensus-chart | Sterling Infrastructure, Inc. Quote

Sterling’s shares increased by 16.3% over the last six months, outperforming the S&P 500, which rose 7.8%. The company boasts a Momentum Score of A.

Sterling Infrastructure, Inc. Price


Sterling Infrastructure, Inc. Price

Sterling Infrastructure, Inc. price | Sterling Infrastructure, Inc. Quote

Atlanta Braves Holdings, Inc. (BATRA)

As the owner and operator of mixed-use real estate developments and the Atlanta Braves MLB team, Atlanta Braves Holdings has a Zacks Rank #1. Over the past 60 days, the Zacks Consensus Estimate for its current year earnings has risen by 24.1%.

Performance Overview


Atlanta Braves Holdings, Inc. Price and Consensus

Atlanta Braves Holdings, Inc. price-consensus-chart | Atlanta Braves Holdings, Inc. Quote

In the past three months, Atlanta Braves’ shares rose by 6.1%, while the S&P 500 saw a decline of 2.2%. The company has a Momentum Score of B.

Atlanta Braves Holdings, Inc. Price


Atlanta Braves Holdings, Inc. Price

Atlanta Braves Holdings, Inc. price | Atlanta Braves Holdings, Inc. Quote

Jazz Pharmaceuticals plc (JAZZ)

This biopharmaceutical firm specializes in neurosciences and oncology, holding a Zacks Rank #1. Recently, the Zacks Consensus Estimate for its current year earnings has seen a 4.8% uptick over the past 60 days.

Performance Overview


Jazz Pharmaceuticals PLC Price and Consensus

Jazz Pharmaceuticals PLC price-consensus-chart | Jazz Pharmaceuticals PLC Quote

Jazz’s shares have grown 16.2% over the past three months, contrasting with the S&P 500’s decline of 2.2%. The company holds a Momentum Score of A.

Jazz Pharmaceuticals PLC Price


Jazz Pharmaceuticals PLC Price

Jazz Pharmaceuticals PLC price | Jazz Pharmaceuticals PLC Quote

For a comprehensive overview, see the full list of top ranked stocks here.

To delve deeper into the Momentum score and its calculation, refer here.

Recently Released: Zacks Top 10 Stocks for 2025

Don’t miss your chance to invest early in our top 10 stocks for 2025. Curated by Zacks Director of Research Sheraz Mian, this portfolio has demonstrated remarkable success. Since its inception in 2012 through November 2024, the Zacks Top 10 Stocks achieved a gain of +2,112.6%, significantly surpassing the S&P 500’s +475.6%. Sheraz has surveyed 4,400 companies covered by the Zacks Rank and selected ten of the best to buy and hold for 2025. You can still be among the first to access these newly released stocks with significant potential.

See New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Download 7 Best Stocks for the Next 30 Days. Get this free report

Jazz Pharmaceuticals PLC (JAZZ): Free Stock Analysis Report

Sterling Infrastructure, Inc. (STRL): Free Stock Analysis Report

Atlanta Braves Holdings, Inc. (BATRA): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.


Subscribe to Pivot and Flow Daily